Sign in
4

Changes in Ownership

RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-21-014656

CFO sold 10,000 shares at an average $35.45 ($354,507)

  • CFO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shenouda Maged · CFO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-08 Exercise or conversion : show line 1 in the form +10,000 $3.24 $32,400 12,228 D
2021-03-08 Sale : show line 2 in the form −100 $35.00 $3,500 12,128 D
2021-03-09 Sale : show line 3 in the form −5,727 $35.42 $202,857 6,401 D
2021-03-09 Sale : show line 4 in the form −1,800 $36.02 $64,836 4,601 D
2021-03-10 Sale : show line 5 in the form −2,373 $35.11 $83,313 2,228 D
Open-market sales · 10,000 sh · avg $35.45 · $354,507

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-08 Exercise or conversion : show line 6 in the form Options to purchase common stock −10,000 70,350 D
Loading xslF345X03/ownership.xml…